Top Markets
#1 Black Phoenix Black Phoenix +167.53%
#2 Islamic Coin Islamic Coin +158.30%
#3 Glidr Glidr +84.34%
#4 Acurast Acurast +29.49%
#5 Test Test +23.70%
#6 Cryptopia Cryptopia +20.92%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.38%
#8 Quantum Resistant Ledger Quantum Resistant Ledger +17.98%
#9 Steem Steem +13.65%
#10 MarsCoin MarsCoin +9.72%
Coin of the day
Black Phoenix Black Phoenix
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Vaxxinity, Inc. Vaxxinity, Inc.

Vaxxinity, Inc.

VAXX
Rang in Aktien #41692
Vaxxinity, Inc., a biotechnology company founded in 2014 and headquartered in... Vaxxinity, Inc., a biotechnology company founded in 2014 and headquartered in Dallas, Texas, is dedicated to advancing novel therapeutic candidates for human application in the United States. Its primary areas of focus are neurological disorders and infectious diseases, particularly those caused by coronaviruses. The company's pipeline features several key programs: UB-311 is a Phase 2 clinical trial candidate targeting toxic aggregated amyloid-beta proteins in the brain, aiming to treat Alzheimer's disease. UB-312, currently in Phase 1 clinical trials, is an investigational therapy designed to address Parkinson's disease and other synucleinopathies, including Lewy body dementia and multiple system atrophy, by targeting detrimental aggregated alpha-synuclein. An anti-tau product candidate is also under development for various neurodegenerative conditions, such as Alzheimer's disease. UB-313 is being developed to alleviate migraines by modulating calcitonin gene-related peptide. An anti-PCSK9 candidate aims to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events by targeting proprotein convertase subtilisin/kexin type 9 serine protease. In the infectious disease segment, UB-612 is a Phase 3 clinical-stage candidate engineered to neutralize the SARS-CoV-2 virus.
Aktienkurs
$0.0001
Zuletzt synchronisiert: 2026-08-11
Marktkapitalisierung
$12.68K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-99.76%
Land
US
Handel Vaxxinity, Inc. (VAXX)

Kategorie

Healthcare
Preis VAXX mit Marktkapitalisierung von B
Vaxxinity, Inc. Vaxxinity, Inc.
VAXX
$0.0001
Marktkapitalisierung von Vaxxinity, Inc.(VAXX)
Marktkapitalisierung: $12.68K
Mit Stand August 2026 hat Vaxxinity, Inc. eine Marktkapitalisierung von $12.68K. Das macht Vaxxinity, Inc. laut unseren Daten zum 41692nd wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Vaxxinity, Inc. von 2021 bis 2026
VAXX im Vergleich zu den Top 5 der beliebtesten stocks
Preis für VAXX Vermögenswert B Marktkapitalisierung von B Ergebnisse
Vaxxinity, Inc. Vaxxinity, Inc.
$42,462.21 $12.68K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.383T +42,462,213,656.11%
Vaxxinity, Inc. Vaxxinity, Inc.
$34,890.29 $12.68K
Apple Inc. Apple Inc.
AAPL
$4.423T +34,890,291,773.62%
Vaxxinity, Inc. Vaxxinity, Inc.
$32,815.66 $12.68K
Alphabet Inc. Alphabet Inc.
GOOG
$4.160T +32,815,660,091.53%
Vaxxinity, Inc. Vaxxinity, Inc.
$28,895.10 $12.68K
Microsoft Corporation Microsoft Corporation
MSFT
$3.663T +28,895,100,365.37%
Vaxxinity, Inc. Vaxxinity, Inc.
$22,805.09 $12.68K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.891T +22,805,085,839.42%